Senolysis of gemcitabine‐induced senescent human pancreatic cancer cells
Abstract Introduction Gemcitabine (GEM) is often used to treat pancreatic cancer. Many anti‐cancer drugs induce cancer cell death, but some cells survive after cell cycle arrest. Such a response to DNA damage is termed cellular senescence. Certain drugs, including the Bcl‐2‐family inhibitor ABT‐263,...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wiley
2024-04-01
|
| Seri Bilgileri: | Cancer Reports |
| Konular: | |
| Online Erişim: | https://doi.org/10.1002/cnr2.2075 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|